Data Spotlight: Sale of Boardvantage is lone M&A deal with disclosed value in May

Disclosed venture-backed M&A fell drastically in May.

Only 15 U.S.-based companies were acquired in the month, down from 23 in April. The only disclosed deal during May was Boardvantage Inc, which Nasdaq Inc acquired for $200 million.

That amounts to a 94 percent decline from April, when seven disclosed transactions combined for $3.3 billion in total value.

Menlo Park, California-based Boardvantage provides corporate-governance software platforms and consultation services. The company had raised $17.7 million in funding, including from Bay Partners and Foundation Capital, according to data from Thomson Reuters.

Two of the 15 venture-backed companies bought in May were in life sciences, according to a VCJ analysis of the data.

BioMedical Enterprises, the San Antonio, Texas, developer of metal implants for musculoskeletal fixation, was bought by DePuy Orthopaedics. Terms weren’t disclosed. BioMedical had raised more than $8 million from Camden Partners Holdings and Cross Atlantic Partners, according to Thomson Reuters.

The other life sciences M&A involved Cayenne Medical Inc, the Scottsdale, Arizona, developer of sports medicine. Zimmer Biomet Holdings acquired the 10-year-old Cayenne, which had raised nearly $50 million from investors.

The company with the most venture funding that was scooped up in May was Livefyre. The San Francisco company, which provides content curation and an audience-engagement platform, had raised more than $85 million in funding from ff Venture Capital, Greycroft Partners, Salesforce Ventures and U.S. Venture Partners, among others. Adobe Systems, which was also an investor, acquired the company.

Downloadable Data: Venture-backed M&A (May 2016)

Photo: Hundred-dollar bills are counted. Reuters/Amr Abdallah Dalsh